We are all carrying microplastics, and one of the more intriguing recent findings suggests that traditional fermented foods may offer a practical way to remove them. Researchers in South Korea, publishing in Bioresource Technology, screened hundreds of bacterial strains and identified a specific lactic acid bacterium found in kimchi that clings tightly to nanoplastics in the gut, keeping them bundled together as they move through the intestine so they can be excreted rather than absorbed into the body. In mice given this strain, plastic particles in the stool more than doubled, suggesting meaningfully better clearance. The idea is that the bacterial cells essentially grab onto the plastic particles and escort them out before they can cross into the bloodstream and accumulate in organs. Two caveats worth noting: this is animal data, and the study was funded by the World Institute of Kimchi. But the mechanism is plausible, kimchi is already well-supported for gut health and immune function, and if live-cultured fermented vegetables can also help bind and eliminate plastic particles, that is a meaningful potential benefit in an era when avoiding nanoplastic exposure entirely is essentially impossible. Look for unpasteurized, live-culture kimchi to ensure the active bacteria are present.

Vitamin E is the collective name for a group of fat soluble nutrients that function as antioxidants to protect cells and tissues. Antioxidants protect cells from free radical damage. Sounds like a sci-fi movie but actually free radicals are all around us (and we even create some ourselves). Free radicals are unstable molecules that damage cells, some well known examples we’ve likely all had exposure to include: - UV rays - Exercise - Cigarette smoke - Environmental pollution - Standard American Diet (SAD) - Alcohol #1 Helps reduce oxidative stress Antioxidants are substances that protect cells from the damaging effects of free radicals, in our environment or produced endogenously. Free radicals are unstable molecules that contain an unshared electron. Free radicals damage cells and might contribute to the development of cardiovascular disease and cancer. Sources of free radicals include those produced internally through physiologic stress like exercise and also environmental exposures including cigarette smoke (first and second hand), UV rays from the sun and pollution. Vitamin E is a free radical scavenger, essentially diffusing the dangerous capabilities of free radicals and protecting cells in the process. Because free radicals have the capability to damage cell membranes, proteins and nucleic acids, they can contribute to cancer risk. Take for example free radicals from UV rays causing skin cancer. Antioxidants including vitamin e, vitamin c and selenium may therefore play a role in cancer prevention and other chronic illness associated with free radical damage. #2 Boosts Immune Function Not only does vitamin E protect cells against damage but it also helps regulate immune function. Vitamin E is involved in regulation of gene expression and cell signalling. Because of its role in immune function, it is found in higher concentrations in immune cells compare to other cells. In fact, research shows it is one of the most effective nutrients that keeps the immune system running smoothly.

For a long time, women in their forties and fifties have been quietly describing a strange new pattern. Foods they have eaten for decades suddenly cause flushing or migraines. Random hives appear without warning. Fragrance triggers headaches. Sleep is disrupted by 3 a.m. heart pounding. Allergies that were once seasonal now feel year-round, and medications they used to tolerate now cause unpredictable reactions. When they raise these concerns, they are often told this is “just menopause” or “just stress.” It is rarely just menopause. What is often happening is a collision between two powerful systems: declining and fluctuating ovarian hormones and an immune system whose mast cells are exquisitely sensitive to those very hormones. A 2026 mini-review published in Frontiers in Allergy by Valerieva and colleagues finally puts a name and a framework around what so many of my patients have lived: menopause profoundly reshapes mast cell behavior, type 2 inflammation, vascular permeability, and skin barrier function, and these changes can either unmask new allergic disease or worsen what was already there. The Valerieva review synthesizes a growing body of evidence suggesting that menopause is not a passive endpoint of reproductive life but an active inflammatory and immunological transition. Estrogen and progesterone modulate mast cell activity, T helper 2 (Th2) inflammation, vascular permeability, and tissue homeostasis. As they fluctuate and decline, the clinical expression of allergic and hypersensitivity disease changes too. The authors describe distinct menopause-related patterns across nearly every allergic condition we see in the clinic: - Asthma: Postmenopausal women, especially after surgical menopause, have an increased risk of new-onset asthma, with body mass index partly mediating this risk. Estrogen receptor alpha activation can amplify type 2 inflammation through CRTh2 upregulation, contributing to asthma severity and even steroid insensitivity in some women. - Allergic and non-allergic rhinitis: Approximately 33% of postmenopausal women report chronic cough lasting longer than eight weeks, and life-long endogenous estrogen exposure has been linked to higher rates of allergic rhinitis later in life. - Anaphylaxis: Postmenopausal women more often present with cardiovascular-dominant manifestations and delayed recovery, and beta-blockers, ACE inhibitors, and NSAIDs (all common in this age group) can amplify reaction severity. - Skin allergies and urticaria: Estrogen decline thins the skin, weakens the barrier, increases mast cell reactivity, and reduces diamine oxidase activity, predisposing midlife women to atopic dermatitis, contact dermatitis, and chronic urticaria. - Drug hypersensitivity: Self-reported drug allergy rises sharply with age, and women over 55 are at higher risk. Estrogen-driven shifts in CYP enzymes (notably a reduction in CYP1A2 activity by up to 50%) alter how medications are metabolized. - Hereditary angioedema: Estrogen-containing hormone therapy can unmask or worsen attacks, while progesterone-only or non-hormonal options are typically better tolerated.

A major Danish study finds no excess mortality, even with long-term use, and signals real benefits after surgical menopause. The study, Menopausal hormone therapy and long-term mortality: nationwide, register-based cohort study, is from Denmark, where they have robust registries they can mine and produce far better observational studies than we can in America. Over 800,000 women were included, with an average follow-up of 14.3 years. Just over 100,000 women filled at least one HRT prescription, more than 15,000 took HRT for 5-10 years, and over 7,000 women had 10 or more years of HRT use. This really shows the power of well-managed databases, because these numbers are just not achievable in a clinical trial. With 12 million person-years of follow-up, the investigators found no “epidemiological evidence of excess mortality following menopausal hormone therapy use. Specifically, they did not see an increase risk for female cancer such as breast, uterine, ovaries, etc. That has been the concerns for the last 30 years is that HRT could increase the risk of certain cancers. But this study, along with several others published in the last 5 years or so, has confirmed that HRT does not cause cancer! I have to mention that HRT was done using bio-identical hormones, but not the synthetic estrogen or progesterone, which could actually increase the risk of cancer.

The A1 vs A2 Milk Distinction: Conventional cow's milk contains two main types of beta-casein protein: A1 and A2. The key difference lies in their amino acid sequences, with A1 beta-casein producing a bioactive peptide, beta-casomorphin-7 (BCM-7), during digestion. A2 milk, on the other hand, comes from cows specially bred to produce only A2 beta-casein. Groundbreaking Clinical Trial: A large-scale study in China has shed new light on the potential benefits of A2 milk for those with self-reported lactose intolerance. This randomized, double-blind trial involved 600 Chinese adults who consumed either conventional milk or milk containing only A2 beta-casein. Key Findings: - Reduced Gastrointestinal Symptoms: Participants reported significantly lower levels of bloating, abdominal pain, and other digestive discomfort after consuming A2 milk compared to conventional milk. - Improved Lactose Digestion: Urinary galactose tests indicated better lactose absorption with A2 milk, even in those classified as lactose malabsorbers. - Consistent Benefits: The positive effects of A2 milk were observed across different age groups and in both lactose absorbers and malabsorbers. While the exact mechanism is not fully understood, researchers hypothesize that A1 beta-casein may trigger gut inflammation, potentially exacerbating symptoms of lactose intolerance. A2 milk, lacking this inflammatory trigger, appears to be better tolerated. Implications for Public Health: These findings could have far-reaching implications for millions who have avoided dairy due to perceived lactose intolerance. By switching to A2 milk, many may be able to reintroduce dairy into their diets, benefiting from its nutritional profile without the associated discomfort. Conclusion: The A2 milk study represents a significant step forward in our understanding of dairy intolerance. While more research is needed, it offers hope to millions who have struggled with dairy consumption. As our knowledge evolves, so too may our approach to nutrition and digestive health.